| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ptc Therapeutics, Inc. (PTCT) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 394.1K | $25.41M | -2,850 | |
| VP | 105.2K | $6.79M | - | |
| CFO | 90.3K | $5.82M | - | |
| Other | 80.1K | $5.17M | - | |
| VP | 79.1K | $5.10M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Klein Matthew B.55 | Chief Executive Officer | Sell | 2,850 | $70.91 | $202,093.50 | -0.7% | - | - | |
| Apr 6, 2026 | Boulding Mark Elliott56 | Exec. VP And CLO | Sale+OE | 2,265 | $69.45 | $157,293.27 | -1.1% | - | - | |
| Apr 2, 2026 | Golden Lee Scott45 | EVP &Chief Medical Officer | Sell | 829 | $67.99 | $56,363.71 | -1.0% | - | - | |
| Apr 1, 2026 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sell | 52,003 | $69.04 | $3,590,242.77 | -21.2% | - | - | |
| Mar 12, 2026 | Klein Matthew B.55 | Chief Executive Officer | Sell | 2,662 | $64.08 | $170,580.96 | -0.7% | - | - | |
| Mar 10, 2026 | Okey Stephanie56 | Director | Sale+OE | 15,167 | $70.00 | $1,061,690.00 | -48.7% | - | - | |
| Jan 12, 2026 | Pauwels Eric62 | Chief Business Officer | Sell | 7,348 | $77.02 | $565,946.00 | -1.7% | -11.5% | - | |
| Jan 9, 2026 | Boulding Mark Elliott56 | Exec. VP And CLO | Sell | 6,347 | $77.06 | $489,080.53 | -0.9% | -8.6% | - | |
| Jan 8, 2026 | Utter Christine Marie58 | SVP, Chief Accounting Officer | Sell | 1,034 | $76.45 | $79,049.30 | -1.4% | -7.3% | - | |
| Jan 8, 2026 | Klein Matthew B.55 | Chief Executive Officer | Sell | 2,514 | $76.45 | $192,195.30 | -0.6% | -7.3% | - |